Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 11.3.2022Viatris Healthcare Limited (VIM-1)53853KLACID 500 mg filmom obalené tablety (tbl flm 14x500 mg (blis.PVC/PVDC/Al))14.3.2022O
 10.3.2022B.Braun Melsungen AG (BME)76566Metronidazol B. Braun 5 mg/ml (sol inf 20x100 ml/500 mg (fľ. PE))7.3.2022R
 10.3.2022Fresenius Kabi AB (FRE)43084SOLUVIT N (lyo ifo 1x10 (liek.inj.skl.))10.3.2022O
 10.3.2022ANPHARM Przedsiebiorstwo Farmaceutyczne S.A. (ANP)8778ATRIPLIXAM 5 mg/1,25 mg/5 mg (tbl flm 30x5 mg/1,25 mg/5 mg (obal PP))10.3.2022R
 10.3.2022ANPHARM Przedsiebiorstwo Farmaceutyczne S.A. (ANP)8780ATRIPLIXAM 5 mg/1,25 mg/5 mg (tbl flm 90(3x30)x5 mg/1,25 mg/5 mg (obal PP))10.3.2022R
 10.3.2022ANPHARM Przedsiebiorstwo Farmaceutyczne S.A. (ANP)8793ATRIPLIXAM 10 mg/2,5 mg/10 mg (tbl flm 30x10 mg/2,5 mg/10 mg (obal PP))10.3.2022R
 10.3.2022Mylan IRE Healthcare Limited (MYR)56801KLACID I.V. (plc ifc 1x500 mg (liek.inj.skl.))10.3.2022O
 10.3.2022ANPHARM Przedsiebiorstwo Farmaceutyczne S.A. (ANP)8790ATRIPLIXAM 10 mg/2,5 mg/5 mg (tbl flm 90(3x30)x10 mg/2,5 mg/5 mg (obal PP))10.3.2022R
 10.3.2022KRKA, d.d., Novo mesto (KRK-2)0667DValtricom 5 mg/160 mg/12,5 mg filmom obalené tablety (tbl flm 90x5 mg/160 mg/12,5 mg (blis.OPA/Al/PVC/Al))14.3.2022O
 10.3.2022KRKA, d.d., Novo mesto (KRK-2)8137ASobycor 2,5 mg filmom obalené tablety (tbl flm 30x2,5 mg (blis.Al/Al))14.3.2022O
 9.3.2022Berlin-Chemie AG (BCE)08137MIG Junior 2% (sus por 1x100 ml (fľ.PET))8.3.2022R
 9.3.2022Mundipharma Gesellschaft m.b.H. (MUP-A-2)22813Targin 10/5 mg tablety s predĺženým uvoľňovaním (tbl plg 60x10 mg/5 mg (blis.PVC/Al))11.3.2022O
 9.3.2022Accord Healthcare Polska Sp. z o.o. (AOK)76909Midazolam Accord 5 mg/ml (sol ijf 1x10 ml/50 mg (amp.skl.))10.3.2022O
 9.3.2022B.Braun Melsungen AG (BME)34252Glukóza B. Braun 5 % infúzny roztok (sol inf 20x100 ml (fľ.LDPE))2.3.2022R
 8.3.2022Upjohn EESV (UPO-NL)85168Revatio 0,8 mg/ml injekčný roztok (sol inj 1x12,5 ml/10 mg ( liek.inj.skl.))8.3.2022R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)